Direxion Daily S&P Biotech Bear 3X ETF (LABD)
NYSEARCA: LABDDirexion FundsTrading--Inverse EquityETFUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LABD chart
Full chartKey facts
- Expense ratio
- 1.07%
- Assets (AUM)
- $80.66M
- Dividend yield
- 6.59%
- Holdings
- —
- Inception
- May 28, 2015
- Issuer
- Direxion Funds
- Index tracked
- —
- Category
- Trading--Inverse Equity
- 52-week range
- 5.81 – 24.82
- Volume / Avg
- 19.34M / 23.69M
- Beta
- —
- Previous close
- 8.41
LABD ETF today
The Direxion Daily S&P Biotech Bear 3X ETF (LABD) is an exchange-traded fund from Direxion Funds in the Trading--Inverse Equity category. It charges an expense ratio of 1.07%, or $107.00 per year on a $10,000 investment, and manages $80.7 million in assets. LABD is down 56.7% year to date and has lost 63.6% over the past 12 months; over five years its price has changed -96.4%.
The fund's trailing dividend yield is 6.59%. LABD launched on May 28, 2015.
Summary generated from market data by MetaCap's automated system. Methodology
LABD performance
1 week
+22.78%
1 month
+22.12%
3 months
+44.83%
6 months
-36.34%
Year to date
-56.74%
1 year
-63.62%
3 years
-95.02%
5 years
-96.38%
LABD price return, excluding dividends.
ETFs similar to LABD
LABD ETF FAQ
What is the LABD price today?
LABD last traded at $9.11 as of Nov 20, 4:00 PM EST, up 8.32% on the day.
What is LABD's expense ratio?
LABD has an expense ratio of 1.07%, which works out to about $107.00 per year for every $10,000 invested.
Does LABD pay a dividend?
Yes. LABD has a trailing dividend yield of 6.59% and pays quarterly distributions; the most recent was $0.071 per share with an ex-dividend date of Sep 22, 2026.
How big is LABD?
LABD has about $80.7 million in assets under management.